Axios on MSN18m
FTC sues to block medical device coatings dealThe Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by ...
MyChesCo on MSN2h
FTC Fights to Block Merger Threatening Healthcare Innovation and Patient-Critical DevicesThe Federal Trade Commission (FTC) has filed a lawsuit seeking to block GTCR BC Holdings, LLC’s (GTCR) proposed acquisition ...
The Rolling Meadows-based insurance broker is pushing back its forecast for when the transaction might close as the ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
This week's Deal Dispatch has updates on Raizen, Walgreens, TikTok and Canoo. Plus: the FTC is blocking mergers like it's ...
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
Gallagher, which in December agreed to buy AssuredPartners from private-equity firms GTCR and Apax Partners, said it is actively responding to FTC request, and that it now expects to complete the ...
House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...
Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.
Gallagher on Friday said the Federal Trade Commission has requested additional information as the antitrust enforcer reviews the deal. The so-called second request by the FTC signals that the agency ...
Lake Street analyst Brooks O’Neil upgraded Surmodics (SRDX) to Buy from Hold with an unchanged price target of $43. The Federal Trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback